Ly P Vu

Ly P Vu

UNVERIFIED PROFILE

Are you Ly P Vu?   Register this Author

Register author
Ly P Vu

Ly P Vu

Publications by authors named "Ly P Vu"

Are you Ly P Vu?   Register this Author

10Publications

462Reads

46Profile Views

mA RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment.

Cell Rep 2019 Aug;28(7):1703-1716.e6

Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2019.07.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818972PMC
August 2019

The Biology of mA RNA Methylation in Normal and Malignant Hematopoiesis.

Cancer Discov 2019 01 21;9(1):25-33. Epub 2018 Dec 21.

Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-18-0959DOI Listing
January 2019

Targeting the Residual Leukemia Cells after Chemotherapy.

Cancer Cell 2018 09;34(3):353-355

Molecular Pharmacology Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108183037
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2018.08.012DOI Listing
September 2018

The N-methyladenosine (mA)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.

Nat Med 2017 Nov 18;23(11):1369-1376. Epub 2017 Sep 18.

Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.4416DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677536PMC
November 2017

Histone-binding of DPF2 mediates its repressive role in myeloid differentiation.

Proc Natl Acad Sci U S A 2017 06 22;114(23):6016-6021. Epub 2017 May 22.

Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1700328114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468650PMC
June 2017

PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complex.

Cell Rep 2013 Dec 12;5(6):1625-38. Epub 2013 Dec 12.

Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; Gerstner Sloan-Kettering Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; Department of Biochemistry and Molecular Biology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL 33136, USA; Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL 33136, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2013.11.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073674PMC
December 2013

Histone-modifying enzymes: their role in the pathogenesis of acute leukemia and their therapeutic potential.

Int J Hematol 2013 Feb 4;97(2):198-209. Epub 2013 Jan 4.

Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-012-1247-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555405PMC
February 2013